Kraus Carl N
Insider CIK 1946475 · AQST Chief Medical Officer · IDRA Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | S Sale | 2025-10-15 | 2025-10-17 | 20,272 | $7.00 | $141.9K | 282,475 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-08-09 | 2025-08-12 | 10,819 | $3.90 | $42.2K | 302,747 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-03-07 | 2025-03-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2025-03-07 | 2025-03-11 | 70,000 | — | $0 | 321,681 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-07 | 2025-03-11 | 8,115 | $2.65 | $21.5K | 313,566 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-08-09 | 2024-08-12 | 10,819 | $3.43 | $37.1K | 251,681 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-03-07 | 2024-03-11 | 56,250 | — | $0 | 56,250 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2024-03-07 | 2024-03-11 | 112,500 | — | $0 | 262,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2023-08-09 | 2023-08-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ACGN Aceragen, Inc. | A Award deriv | 2023-01-20 | 2023-02-02 | 25,400 | — | $0 | 25,400 | SEC↗ |
| ACGN Aceragen, Inc. | M Exercise deriv | 2023-01-17 | 2023-01-19 | 440,844 | — | $0 | 440,844 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-09-28 | 2022-09-30 | 6,843 | — | $0 | 6,843 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-09-28 | 2022-09-30 | 6,843 | — | $0 | 6,843 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-09-28 | 2022-09-30 | 651,364 | — | $0 | 651,364 | SEC↗ |